The data displays the development of the revenue of Dutch biotech company Qiagen from 2012 to 2017. In 2016, net sales of this company stood at 1.34 billion USD. Qiagen N.V. is headquartered in the Netherlands and in Germany, and is operating in many countries around the world. The company is specialized on sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
2012 | 1254.5 |
2013 | 1302 |
2014 | 1344.8 |
2015 | 1281 |
2016 | 1338 |
2017 | 1417.5 |